mabuterol has been researched along with Obstructive Lung Diseases in 1 studies
mabuterol: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mabuterol was found to have a good, clinically useful, bronchodilating effect and to possess excellent tolerability at doses of 40-60 micrograms." | 2.65 | Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol. ( Baines, A; Scholz, HJ; Ulmer, WT, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulmer, WT | 1 |
| Scholz, HJ | 1 |
| Baines, A | 1 |
1 trial available for mabuterol and Obstructive Lung Diseases
| Article | Year |
|---|---|
Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Airway Resistance; Blood Pressure; Bronchodilator Agents; Cle | 1984 |